These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1954924)

  • 1. Human somatic mutation assays as biomarkers of carcinogenesis.
    Compton PJ; Hooper K; Smith MT
    Environ Health Perspect; 1991 Aug; 94():135-41. PubMed ID: 1954924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo somatic mutations in humans: measurement and analysis.
    Albertini RJ; Nicklas JA; O'Neill JP; Robison SH
    Annu Rev Genet; 1990; 24():305-26. PubMed ID: 2088171
    [No Abstract]   [Full Text] [Related]  

  • 3. Human somatic mutation--where are we going?
    Morley AA
    Prog Clin Biol Res; 1990; 340C():1-4. PubMed ID: 2381918
    [No Abstract]   [Full Text] [Related]  

  • 4. Somatic gene mutations in humans.
    Menichini P; Abbondandolo A
    Prog Clin Biol Res; 1991; 372():267-79. PubMed ID: 1956924
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of four somatic mutation assays for biological dosimetry of radiation-exposed people including atomic bomb survivors.
    Nakamura N; Umeki S; Hirai Y; Kyoizumi S; Kushiro J; Kusunoki Y; Akiyama M
    Prog Clin Biol Res; 1991; 372():341-50. PubMed ID: 1956929
    [No Abstract]   [Full Text] [Related]  

  • 6. The HLA-A mutation assay: improved technique and normal results.
    McCarron MA; Kutlaca A; Morley AA
    Mutat Res; 1989 Apr; 225(4):189-93. PubMed ID: 2927440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple biological markers in germ cell tumor patients treated with platinum-based chemotherapy.
    Perera FP; Motzer RJ; Tang D; Reed E; Parker R; Warburton D; O'Neill P; Albertini R; Bigbee WL; Jensen RH
    Cancer Res; 1992 Jul; 52(13):3558-65. PubMed ID: 1319825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo mutations in human blood cells: biomarkers for molecular epidemiology.
    Albertini RJ; Nicklas JA; Fuscoe JC; Skopek TR; Branda RF; O'Neill JP
    Environ Health Perspect; 1993 Mar; 99():135-41. PubMed ID: 8319611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intercorrelations and sources of variability in three mutagenicity assays: a population-based study.
    Radack K; Martin V; Wones R; Buncher R; Pinney S; Mandell K
    Mutat Res; 1996 Mar; 350(2):295-306. PubMed ID: 8600359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches for biological monitoring of radiation workers.
    Mendelsohn ML
    Health Phys; 1990 Jul; 59(1):23-8. PubMed ID: 2358356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glycophorin A assay for somatic cell mutations in humans.
    Langlois RG; Bigbee WL; Jensen RH
    Prog Clin Biol Res; 1990; 340C():47-56. PubMed ID: 2199987
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of bromodeoxyuridine labeling in the human lymphocyte HGPRT somatic mutation assay.
    Ostrosky-Wegman P; Montero MR; de Nava CC; Tice RR; Albertini R
    Mutat Res; 1987; 191(3-4):211-4. PubMed ID: 3627157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for cellular mutational assays in human populations.
    Mendelsohn ML
    Basic Life Sci; 1985; 33():415-27. PubMed ID: 4015593
    [No Abstract]   [Full Text] [Related]  

  • 14. Bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) gene promoter polymorphisms and HPRT, glycophorin A, and micronuclei mutant frequencies in human blood.
    Grant DJ; Hall IJ; Eastmond DA; Jones IM; Bell DA
    Mutat Res; 2004 May; 560(1):1-10. PubMed ID: 15099818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of somatic mutants in man: HPRT mutations in lymphocytes and hemoglobin mutations in erythrocytes.
    Tates AD; Bernini LF; Natarajan AT; Ploem JS; Verwoerd NP; Cole J; Green MH; Arlett CF; Norris PN
    Mutat Res; 1989 Jul; 213(1):73-82. PubMed ID: 2747707
    [No Abstract]   [Full Text] [Related]  

  • 16. Somatic mutation and aging.
    Morley A
    Ann N Y Acad Sci; 1998 Nov; 854():20-2. PubMed ID: 9928416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of exogenous and endogenous mutagens to in vivo mutations.
    Morley AA; Turner DR
    Mutat Res; 1999 Jul; 428(1-2):11-5. PubMed ID: 10517973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutation in peripheral lymphocytes of former workers at the Okunojima poison gas factory.
    Yanagida J; Hozawa S; Ishioka S; Maeda H; Takahashi K; Oyama T; Takaishi M; Hakoda M; Akiyama M; Yamakido M
    Jpn J Cancer Res; 1988 Dec; 79(12):1276-83. PubMed ID: 3148597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic cell genotoxicity at the glycophorin A locus in humans.
    Jensen RH; Grant SG; Langlois RG; Bigbee WL
    Prog Clin Biol Res; 1991; 372():329-39. PubMed ID: 1956927
    [No Abstract]   [Full Text] [Related]  

  • 20. Somatic-cell mutations as a possible predictor of cancer risk.
    Akiyama M; Umeki S; Kusunoki Y; Kyoizumi S; Nakamura N; Mori T; Ishikawa Y; Yamakido M; Ohama K; Kodama T
    Health Phys; 1995 May; 68(5):643-9. PubMed ID: 7730060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.